⇓Carlos M. Ferrario, M.D., is an Argentine-born cardiologist whose research has advanced understanding and treatment of high blood pressure and vascular disease. A graduate of the University of Buenos Aires Medical School in 1963, Dr Ferrario pursued postgraduate training in cardiology at the University of Göteborg and the Karolinska Institute in Sweden between 1964 and 1966.
Dr Ferrario joined Dr Irvine H. Page, a pioneer in hypertension research, at The Cleveland Clinic Foundation in 1966. Under his mentorship, Dr Ferrario developed a premier program on the neural and endocrine causes of hypertension. Dr Ferrario chaired the Department of Brain and Vascular Research of the Cleveland Clinic Foundation from 1984 to 1992. He assumed the directorship of the Hypertension and Vascular Disease Center of the Wake Forest University School of Medicine in 1992 and founded the Consortium for Southeastern Hypertension Control (COSEHC).
Dr Ferrario’s research has encompassed multiple areas of hypertension, including the central nervous system actions of angiotensin, the role of the sympathetic nervous system in cardiac hypertrophy, new pathways for formation of angiotensin peptides, and the functions of angiotensin-(1-7). His recent studies on the role of the renin angiotensin system in the pathogenesis of atherosclerosis has lead to increased understanding of the interaction between lipids and endocrine hormones in the evolution of atherosclerosis.
Dr Ferrario has published over 385 papers and 2 books and has mentored many physicians who have become medical leaders in the United States, Japan, and Latin America. He has served as president of the Inter-American Society of Hypertension and is a fellow of the American College of Cardiology, the Council for High Blood Pressure Research, the American College of Angiology, and the Southern Society for Clinical Investigation. He also served as a member of the editorial boards of the journals Hypertension, Circulation, American Journal of Physiology, Clinical and Experimental Hypertension, the Spanish Journal of Hypertension, and Japan’s Journal of Hypertension Research. He is a member of the Joint National Commission (JNC-VI) of the National High Blood Pressure Education Program of the National Heart, Lung, and Blood Institute and chair of the National Institutes of Health Review Panel for Specialized Centers of Research in the Genetics of Hypertension.
Dr Ferrario is a former Established Investigator and the recipient of the Harry Goldblatt Award from the American Heart Association. In 1998, Dr Ferrario received the Ignacio Chaves Centennial Gold Medal of Honor from the National University of Mexico, and in 1999, he received the European Society of Hypertension Angiotensin II Investigator of the Year Award. He was selected as the 1999 recipient of the prestigious Wake Forest University School of Medicine Established Investigator in Clinical Science award. And in 2001, he received the Robert Tigerstedt Award from the American Society of Hypertension for his discoveries in the field of hypertension research. The Inter-American Society on Hypertension is proud to present to Dr Carlos Ferrario the 2003 Lifetime Achievement Award.